24.06.2024 08:07:05 - dpa-AFX: *GSK: EMA ACCEPTS JEMPERLI+ CHEMOTHERAPY APPLICATION FOR REVIEW TO EXPAND USE FOR PATIENTS WITH ENDOMETRIAL CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
GSK PLC LS-,3125 A3DMB5 Xetra 18,040 05.07.24 11:44:40 +0,185 +1,04% 17,985 18,015 17,875 17,855

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH